首页> 外文期刊>British Journal of Clinical Pharmacology >Effectiveness of medication review on the number of drug‐related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial
【24h】

Effectiveness of medication review on the number of drug‐related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial

机译:药物综述对访问门诊心脏病学诊所患者毒药有关问题数量的有效性:随机对照试验

获取原文
获取原文并翻译 | 示例
       

摘要

Aims To assess the effectiveness of medication review on the number of drug‐related problems (DRPs) in outpatient cardiology patients. Methods In this randomized controlled trial, a computer‐assisted and pharmacist‐led medication review with patient involvement (questionnaire and telephone call with pharmacist) was conducted in intervention patients prior to their visit to the cardiologist. The control group received usual care. Adult outpatient cardiology patients without support concerning the administration of medication, without a medication review in the past 6 months and who gave permission to access their electronic medication record were included. The primary outcome measure was the number of DRPs 1 month after the visit. Secondary outcome measures concerned the type of DRP and the type of medication involved in the DRPs. Results In total, 75 patients (mean [standard deviation, SD] age 66.0 [12.5] years, 41% female) were included. Intervention ( n = 90) and control group ( n = 85) were comparable at baseline. The mean (SD) number of drugs used per patient was 7.9 (3.9). After 1 month, the mean (SD) number of DRPs was 0.3 (0.7) and 0.8 (1.0) and the median (range) number of DRPs was 0 (0–4) and 0 (0–4) in the intervention group and control group, respectively ( P .001). In the intervention group, 74% of the DRPs identified at T0 were solved at T1 vs 14% in the control group. Conclusion This randomized controlled trial suggests that a pharmacist‐led medication review in patients with a scheduled visit to the outpatient cardiology clinic decreases the number of DRPs.
机译:旨在评估药物审查对门诊心脏病学患者的药物相关问题数量的有效性。方法在这种随机对照试验中,在访问心脏病专家之前,在干预患者中进行了一种与患者参与(调查问卷和电话呼叫的药剂师的药剂师LED药物治疗方法。对照组接受了通常的护理。成人门诊心脏病学患者无需支持药物施用,在过去的6个月内没有药物审查,并允许获得获得电子药物的许可。主要结果措施是访问后1个月的DRPS数量。次要结果措施涉及DRP的类型和DRP所涉及的药物类型。结果总计75名患者(平均值[标准偏差,SD]年龄66.0岁[12.5],41%的女性)。干预(n = 90)和对照组(n = 85)在基线上可比较。平均(SD)每位患者使用的药物数量为7.9(3.9)。 1个月后,平均值(SD)的DRPS为0.3(0.7)和0.8(1.0),中位数(范围)DRP的数量为0(0-4),并且在干预组中为0(0-4)对照组分别(P& .001)。在干预组中,在对照组的T1 Vs 14%下鉴定的74%的DRP溶解。结论该随机对照试验表明,预定访问门诊心脏病学诊所的患者的药剂师LED药物审查降低了DRP的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号